Idexx Laboratories Stock Buy Hold or Sell Recommendation
| IDXX Stock | USD 476.35 1.44 0.30% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding IDEXX Laboratories is 'Hold'. Macroaxis provides IDEXX Laboratories buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding IDXX positions. The advice algorithm takes into account all of IDEXX Laboratories' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting IDEXX Laboratories' buy or sell advice are summarized below:
Real Value 535.67 | Target Price 569.13 | Hype Value 476.36 | Market Value 476.35 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell IDEXX Laboratories given historical horizon and risk tolerance towards IDEXX Laboratories. When Macroaxis issues a 'buy' or 'sell' recommendation for IDEXX Laboratories, the advice is generated through an automated system that utilizes algorithms and statistical models.
IDEXX |
Execute IDEXX Laboratories Buy or Sell Advice
The IDEXX recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on IDEXX Laboratories. Macroaxis does not own or have any residual interests in IDEXX Laboratories or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute IDEXX Laboratories' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Small | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Strong | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
IDEXX Laboratories Trading Alerts and Improvement Suggestions
| IDEXX Laboratories generated a negative expected return over the last 90 days | |
| IDEXX Laboratories is unlikely to experience financial distress in the next 2 years | |
| The company currently holds 947.88 M in liabilities with Debt to Equity (D/E) ratio of 3.28, implying the company greatly relies on financing operations through barrowing. IDEXX Laboratories has a current ratio of 0.87, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist IDEXX Laboratories until it has trouble settling it off, either with new capital or with free cash flow. So, IDEXX Laboratories' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like IDEXX Laboratories sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for IDEXX to invest in growth at high rates of return. When we think about IDEXX Laboratories' use of debt, we should always consider it together with cash and equity. | |
| IDEXX Laboratories has a strong financial position based on the latest SEC filings | |
| Over 93.0% of IDEXX Laboratories shares are owned by institutional investors | |
| Latest headline from zacks.com: TMO vs. IDXX Which Stock Is the Better Value Option |
IDEXX Laboratories Returns Distribution Density
The distribution of IDEXX Laboratories' historical returns is an attempt to chart the uncertainty of IDEXX Laboratories' future price movements. The chart of the probability distribution of IDEXX Laboratories daily returns describes the distribution of returns around its average expected value. We use IDEXX Laboratories price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of IDEXX Laboratories returns is essential to provide solid investment advice for IDEXX Laboratories.
| Mean Return | -0.12 | Value At Risk | -2.31 | Potential Upside | 1.90 | Standard Deviation | 1.63 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of IDEXX Laboratories historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
IDEXX Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as IDEXX Laboratories is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading IDEXX Laboratories backward and forwards among themselves. IDEXX Laboratories' institutional investor refers to the entity that pools money to purchase IDEXX Laboratories' securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Brown Advisory Holdings Inc | 2023-12-31 | 1.2 M | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 1.1 M | Capital World Investors | 2023-12-31 | 1 M | Norges Bank | 2023-12-31 | 922.8 K | Northern Trust Corp | 2023-12-31 | 862.6 K | Jpmorgan Chase & Co | 2023-12-31 | 860.5 K | Fundsmith Investment Services Ltd. | 2023-12-31 | 818.6 K | Legal & General Group Plc | 2023-12-31 | 787.2 K | Principal Financial Group Inc | 2023-12-31 | 781.4 K | Blackrock Inc | 2023-12-31 | 9.1 M | Vanguard Group Inc | 2023-12-31 | 8.4 M |
IDEXX Laboratories Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (37.3M) | (18.9M) | (52.9M) | (121.7M) | (28.7M) | (27.2M) | |
| Change In Cash | (33.5M) | 293.6M | (239.5M) | (31.9M) | 341.4M | 358.5M | |
| Free Cash Flow | 303.9M | 540.4M | 636.0M | 394.1M | 772.9M | 811.5M | |
| Depreciation | 88.0M | 96.0M | 104.6M | 111.9M | 114.9M | 120.7M | |
| Other Non Cash Items | 2.9M | 8.8M | 9.3M | 10.8M | 7.6M | 7.9M | |
| Capital Expenditures | 155.2M | 107.6M | 119.5M | 148.8M | 133.6M | 140.3M | |
| Net Income | 427.8M | 582.1M | 744.8M | 679.1M | 845.0M | 887.3M | |
| End Period Cash Flow | 90.3M | 383.9M | 144.5M | 112.5M | 453.9M | 476.6M | |
| Investments | (205.5M) | (109.4M) | (293.0M) | (195.4M) | (144.0M) | (136.8M) | |
| Change Receivables | (22.5M) | (60.7M) | (33.1M) | (41.4M) | (37.3M) | (39.1M) | |
| Net Borrowings | (10.4M) | (94.7M) | 23.5M | 430.1M | 387.1M | 406.4M | |
| Change To Netincome | 48.3M | 1.7M | 148.2M | 25.5M | 29.4M | 28.4M |
IDEXX Laboratories Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to IDEXX Laboratories or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that IDEXX Laboratories' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a IDEXX stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.19 | |
β | Beta against NYSE Composite | 1.07 | |
σ | Overall volatility | 1.63 | |
Ir | Information ratio | -0.11 |
IDEXX Laboratories Volatility Alert
IDEXX Laboratories exhibits very low volatility with skewness of 2.27 and kurtosis of 11.24. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure IDEXX Laboratories' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact IDEXX Laboratories' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.IDEXX Laboratories Fundamentals Vs Peers
Comparing IDEXX Laboratories' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze IDEXX Laboratories' direct or indirect competition across all of the common fundamentals between IDEXX Laboratories and the related equities. This way, we can detect undervalued stocks with similar characteristics as IDEXX Laboratories or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of IDEXX Laboratories' fundamental indicators could also be used in its relative valuation, which is a method of valuing IDEXX Laboratories by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare IDEXX Laboratories to competition |
| Fundamentals | IDEXX Laboratories | Peer Average |
| Return On Equity | 0.81 | -0.31 |
| Return On Asset | 0.23 | -0.14 |
| Profit Margin | 0.23 % | (1.27) % |
| Operating Margin | 0.27 % | (5.51) % |
| Current Valuation | 41.29 B | 16.62 B |
| Shares Outstanding | 83.05 M | 571.82 M |
| Shares Owned By Insiders | 0.92 % | 10.09 % |
| Shares Owned By Institutions | 92.56 % | 39.21 % |
| Number Of Shares Shorted | 1.76 M | 4.71 M |
| Price To Earning | 61.31 X | 28.72 X |
| Price To Book | 27.85 X | 9.51 X |
| Price To Sales | 11.29 X | 11.42 X |
| Revenue | 3.66 B | 9.43 B |
| Gross Profit | 2 B | 27.38 B |
| EBITDA | 1.1 B | 3.9 B |
| Net Income | 845.04 M | 570.98 M |
| Cash And Equivalents | 114.36 M | 2.7 B |
| Cash Per Share | 1.37 X | 5.01 X |
| Total Debt | 947.88 M | 5.32 B |
| Debt To Equity | 3.27 % | 48.70 % |
| Current Ratio | 0.89 X | 2.16 X |
| Book Value Per Share | 17.88 X | 1.93 K |
| Cash Flow From Operations | 906.51 M | 971.22 M |
| Short Ratio | 4.54 X | 4.00 X |
| Earnings Per Share | 10.04 X | 3.12 X |
| Price To Earnings To Growth | 4.75 X | 4.89 X |
| Target Price | 604.62 | |
| Number Of Employees | 11 K | 18.84 K |
| Beta | 1.26 | -0.15 |
| Market Capitalization | 40.66 B | 19.03 B |
| Total Asset | 3.26 B | 29.47 B |
| Retained Earnings | 4.44 B | 9.33 B |
| Working Capital | 543.71 M | 1.48 B |
Note: Disposition of 680 shares by James Polewaczyk of IDEXX Laboratories at 559.3318 subject to Rule 16b-3 [view details]
IDEXX Laboratories Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as IDEXX . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 11453.16 | |||
| Daily Balance Of Power | (0.13) | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 476.82 | |||
| Day Typical Price | 476.66 | |||
| Price Action Indicator | (1.18) | |||
| Period Momentum Indicator | (1.44) |
About IDEXX Laboratories Buy or Sell Advice
When is the right time to buy or sell IDEXX Laboratories? Buying financial instruments such as IDEXX Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 458.9M | 433.7M | 478.7M | 502.6M | Total Assets | 2.4B | 2.7B | 3.3B | 3.4B |
Use Investing Ideas to Build Portfolios
In addition to having IDEXX Laboratories in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Heavy Metals Thematic Idea Now
Heavy Metals
Companies involved in mining, production, and distribution of various industrial metals and minerals. The Heavy Metals theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Heavy Metals Theme or any other thematic opportunities.
| View All Next | Launch |
Check out IDEXX Laboratories Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Complementary Tools for IDEXX Stock analysis
When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |
Is IDEXX Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IDEXX Laboratories. If investors know IDEXX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IDEXX Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.121 | Earnings Share 10.04 | Revenue Per Share 44.073 | Quarterly Revenue Growth 0.088 | Return On Assets 0.2283 |
The market value of IDEXX Laboratories is measured differently than its book value, which is the value of IDEXX that is recorded on the company's balance sheet. Investors also form their own opinion of IDEXX Laboratories' value that differs from its market value or its book value, called intrinsic value, which is IDEXX Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IDEXX Laboratories' market value can be influenced by many factors that don't directly affect IDEXX Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IDEXX Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if IDEXX Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IDEXX Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.